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Abstract
Introduction: Drug shops are a major source of care for children in low income
countries but they provide sub-standard care. We assessed the feasibility and
effect on quality of care of introducing diagnostics and pre-packaged paediatric-
dosage drugs for malaria, pneumonia and diarrhoea at drug shops in Uganda.
Methods: We adopted and implemented the integrated community case
management (iCCM) intervention within registered drug shops. Attendants were
trained to perform malaria rapid diagnostic tests (RDTs) in each fever case and
count respiratory rate in each case of cough with fast/difficult breathing, before
dispensing recommended treatment. Using a quasi-experimental design in one
intervention and one non-intervention district, we conducted before and after exit
interviews for drug seller practices and household surveys for treatment-seeking
practices in May–June 2011 and May–June 2012. Survey adjusted generalized
linear models and difference-in-difference analysis was used.
Results: 3759 (1604 before/2155 after) household interviews and 943 (163 before/
780 after) exit interviews were conducted with caretakers of children under-5. At
baseline, no child at a drug shop received any diagnostic testing before treatment in
both districts. After the intervention, while no child in the non-intervention district
received a diagnostic test, 87.7% (95% CI 79.0–96.4) of children with fever at the
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intervention district drug shops had a parasitological diagnosis of malaria, prior to
treatment. The prevalence ratios of the effect of the intervention on treatment of
cough and fast breathing with amoxicillin and diarrhoea with ORS/zinc at the drug
shop were 2.8 (2.0–3.9), and 12.8 (4.2–38.6) respectively. From the household
survey, the prevalence ratio of the intervention effect on use of RDTs was 3.2 (1.9–
5.4); Artemisinin Combination Therapy for malaria was 0.74 (0.65–0.84), and ORS/
zinc for diarrhoea was 2.3 (1.2–4.7).
Conclusion: iCCM can be utilized to improve access and appropriateness of care
for children at drug shops.
Introduction
After the first month of life, about half of mortality in children under five years of
age in sub-Saharan Africa is caused by malaria, pneumonia and diarrhoea. [1]
These three illnesses usually manifest as an acute febrile illness, with overlapping
symptoms. Following on from lessons learned in the public sector roll out of
Integrated Management of Childhood Illness (IMCI) [2, 3], the integrated
Community Case Management (iCCM) of malaria, pneumonia and diarrhoea
targets the community level for integration of diagnostics with pre-packaged
drugs for these illnesses. iCCM is now being scaled up through the efforts of
UNICEF, WHO and several large donors. [4]
Under the iCCM strategy, lay community members are empowered to diagnose
and treat malaria, pneumonia and diarrhoea using diagnostics (malaria rapid
diagnostic tests - RDTs - and respiratory timers) and the dose specific pre-
packaged drugs: artemisinin combination therapy (ACTs), dispersible amoxicillin
tablets and oral rehydration salts/zinc sulphate (ORS/zinc) respectively.
Consequently, Uganda [5] and other low income countries have now adopted a
policy of iCCM implemented primarily through Community Health Workers
(CHW).
However, about 60% of parents with febrile children in Uganda first seek care
in the private sector, especially at drug shops. [6] Unfortunately, the standard of
care in these drug shops is poor. [7, 8]
Recognizing the high utilization of the private sector and drugs shops for fever
treatment in low income countries, the Global Fund through the Affordable
Medicines Facility – Malaria (AMFm) in 2010 subsidized ACTs for both the
public and private sector in a pilot study in 8 countries. [9] An independent
evaluation of the AMFm pilot concluded that subsidies combined with supporting
interventions were effective in rapidly improving availability, price and market
share of quality assured ACTs in the private-for-profit sector. [10, 11] However,
the lack of programmatic integration of RDTs in the AMFm presumably led to
widespread presumptive treatment of fever with anti-malaria drugs only.
Einhorn Family Foundation had no role in study
design, data collection, data analysis, interpretation
or writing the report. Medicines for Malaria Venture
participated in all the above stages. The corre-
sponding author had full access to all the data in
the study and had the final responsibility for the
decision to submit for publication.
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While the AMFm may have encouraged presumptive treatment of fever with
antimalaria drugs, malaria RDTs are now available, allowing rapid detection of
‘‘RDT-negative fever’’, prompting the need for alternative appropriate treatment.
Also, WHO now recommends parasitological diagnosis of malaria for all patients,
including children less than 5 years, prior to treatment. [12]The challenge now is
to integrate both diagnostics, and alternative appropriate treatment, [13] in order
to simultaneously achieve rational use of drugs for both antimalarials and
antibiotics, at the same time as good quality of care for the febrile child,
irrespective of cause of fever.
As drug shops remain a major source of care for febrile children in low income
countries, there is a need to study interventions aimed at improving their quality
of care in the management of common febrile childhood illnesses. We set out to
assess the feasibility and effect on access and appropriateness of treatment when
we introduce diagnostics (RDT and respiratory timers) and promote pre-
packaged paediatric-dosage drugs for acute febrile illnesses (malaria and
pneumonia) and diarrhoea at private sector drug shops.
Methods
Study site
The study was conducted in two rural neighbouring districts of eastern Uganda
located approximately 150 km north-east of the capital Kampala: Kaliro district
(est. 216,000 inhabitants 2010) as the intervention district and Kamuli district
(est. 270,000 inhabitants 2010) as the non-intervention or comparison district.
This is a high malaria transmission area with estimated parasite prevalence of over
60% in school-age children. [14] These districts were also chosen because they had
both participated in a previous study, the Consortium for ACT Private Sector
Subsidy (CAPSS) pilot study where ACTs for malaria had been made available in
registered drug shops. [15]
Study design
This was a quasi-experimental study in one intervention and one non-
intervention or comparison district using a plausibility design with before and
after measurement, in line with current WHO/Alliance for Health Policy and
Systems research recommendations. [16] The chosen plausibility design
comparing two entire districts was deemed the most suitable given that the
registered drug shops are supervised from district level, and that both supervisors
and patients would likely have contaminated the study if individual drug shops
had been randomized in a probability design.
This was a two phased study. In the first phase, prior to the intervention, we set
out to determine the community care seeking and treatment practices as well as
drug-seller treatment practices. Given that appropriateness of treatment for
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children with fever, cough with fast breathing or diarrhoea within the community
and at drug shops was not known, we set out to determine these.
In phase two, (one year later after the intervention) we then determined the
effect of the intervention on access to care and appropriateness of treatment in the
community as well as at drug shops.
The intervention
There were three main components of the intervention: 1) provision of dose
specific pre-packaged and subsidized drugs and diagnostics to registered drug
shops drugs; 2) training of drug shop attendants and 3) a community awareness
campaign.
Modelled on the public sector iCCM intervention for community health
workers, all registered drug shops in the intervention district received the
following: subsidised drugs: The drugs were pre-packaged as unit doses and
included: dispersible ACTs from Uganda’s AMFm pilot; amoxicillin tablets
(dispersible); low osmolar oral rehydration solution (ORS) and zinc sulphate
tablets (dispersible) which were sold at a mark-up of 50–80% (typically buying at
USD 0.25 and selling at USD 0.38). Free diagnostics: malaria RDTs; respiratory
timers and diagnostic algorithms/charts. Training: Two drug shop attendants per
drug shop received a 5-day training on how to use the diagnostics and dispense
pre-packaged drugs including daily clinical sessions in a public health facility. The
training was conducted by the Ministry of Health using the national iCCM
training manual for community health workers, adapted for drug shop attendants.
Drug shop attendants were trained to perform RDTs in each fever case and count
respiratory rate in each case of cough with fast/difficult breathing prior to
dispensing the appropriate recommended treatment.
The non-intervention district continued the current practice of distributing
subsidized ACTs only under AMFm support and guidelines, relying upon
previous training. This previous training was conducted by Ministry of Health
trainers and the (CAPSS) pilot study [15] which had ended just prior to the start
of our intervention and focused on treatment of malaria. The non-intervention
district had also received an awareness campaign on improved treatment seeking
for febrile children which was conducted by the CAPSS pilot study. Additional
awareness information on appropriate care-seeking was provided through the
district/community radios in the non-intervention area during the intervention
period.
The community awareness campaign in the intervention district was conducted
by Population Services International (PSI)/Programme for Accessible Health
Communication and Education (PACE) in Uganda. This included branding of the
drug shops, communicating with caretakers of children and providing informa-
tion at markets, public gatherings and on community radios, on appropriate care-
seeking.
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The intervention began in August 2011 and was implemented at full scale from
September 2011 until August 2012. Fig. 1 shows the study design and timing of
the intervention and data collection.
Eligibility criteria
All 84 drug shops registered by the Uganda National Drug Authority (NDA) in
the intervention (44 shops) and non-intervention district (40 shops) were
included in the study. Un-registered drug shops, small shops and mobile medicine
vendors were excluded as required by the NDA.
All caretakers and children for whom care was sought in a drug shop or who
were residing in the participating districts were eligible to participate in the study.
Fig. 1. Study design and timing of interventions and data collection.
doi:10.1371/journal.pone.0115440.g001
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Data collection
Data collection was conducted both at baseline from May–June 2011 and at
follow-up from May–June 2012 in both the intervention and non-intervention
districts, using structured questionnaires. A 5-day training was conducted for data
collectors including a pilot assessment outside the study clusters.
We conducted household interviews for community treatment practices (1604
before/2155 after) and exit interviews at drug shops for drug seller treatment
practices (163 before/780 after).
Exit interviews at drug shops
All clients exiting the drug shops were approached and asked to participate in an
interview using a semi-structured questionnaire, if they had come to the drug
shop seeking treatment for a child less than 5 years of age. Data collectors were at
the drug shop all day, from 8:30 am–7:00 pm for a total of four weeks. We also
recorded information on the medicines purchased including the drug name,
dosage and duration of treatment.
Household survey
A two stage cluster sampling using probability proportional to population size was
used to select 1604 households in both the intervention and non-intervention
districts at baseline and 2155 households at follow up, with children less than 5
years of age. At the first stage a probability sample of 30 villages/clusters were
sampled, the same before and after. At the second stage, individual households
were sampled from each cluster, not identical before and after. The study team
randomly identified a starting point from a list of households obtained from the
local leaders (village level household enumeration lists for local elections) and
thereafter sampled every fifth household with children less than 5 years of age. The
main caretaker (usually the mother) aged 15 years and above was interviewed
face-to-face using a semi-structured questionnaire, designed to elicit treatment
and care seeking practice for the most recent illness, less than 2 weeks prior to the
interview. If there was no child under 5 years of age at the sampled house, the very
next house was visited.
Direct observation
In order to directly assess quality of management of sick children by drug sellers,
we randomly selected half of the participating drug shops in the intervention area
and directly observed the drug sellers manage 2–3 sick children each. A field
supervisor (a nurse) trained in iCCM, observed the drug sellers. This person
recorded all the presenting complaints of the children observed, the assessment
done by the drug seller and treatment given. At the same time, she made her own
assessment of the child and recorded this.
Sample size calculation
This was a two phased study. During phase one, sample size for the household
survey was calculated to determine prevalence of appropriate treatment of sick
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children in the study area which was previously unknown and so was taken as
50%, using 95% confidence interval; a 5% margin of error and a design effect of 2.
For exit interviews, data from all children with fever or cough with fast/difficult
breathing or diarrhoea, for whom care was sought at all participating drug shops
(both intervention and non-intervention combined) was collected, in order to
estimate appropriateness of treatment provided at drug shops as previously
published [7].
Phase 2: Informed by the baseline findings, the sample size (end line) for
household survey was calculated based on baseline prevalence of appropriate
treatment of fever and cough with rapid/difficult breathing, assuming 50%
increase in correct treatment between baseline and end line, a 5% margin of error
and a design effect of 2.
The outcome of interest was ‘‘appropriate treatment’’ of children in the
community with each of the three symptoms: fever, cough and rapid/difficult
breathing, or diarrhoea. Appropriate treatment was thus defined as: a child with
fever in the community treated with ACTs; a child with cough and rapid/difficult
breathing treated with amoxicillin and a child with diarrhoea treated with ORS/
zinc.
For the exit interviews, end line sample size was calculated based on the
prevalence of appropriate treatment of children at drug shops of 10%; 100%
increase in appropriate treatment of children (i.e. 10% to 20%); 95% confidence
level; and a 5% margin of error. For logistical reasons, in order to answer a
different objective on community adherence to drugs, the sample size at end line
in the intervention area is higher than that in the non-intervention area.
Data analysis
The data was entered in Epi Data (www.epidata.dk), and was analysed using stata
version 12 (www.stata.com). Baseline and follow up data was analysed separately
and the baseline findings of the 2 districts combined have now been published. [7]
For this paper, survey-adjusted generalized linear models (log transformation
and binomial distribution) and difference-in-difference analysis was used for both
exit interviews and household surveys data. Descriptive statistics were generated
separately for the intervention and non-intervention districts at each of the data
collection rounds (before and after) and the differences between/within
intervention and non-intervention areas are presented in terms of p-values.
Survey-adjusted differences in management of children before and after the
intervention were also calculated with intervention status as the exposure. Finally,
survey-adjusted prevalence ratios of the intervention effect on appropriate
treatment of malaria, pneumonia and diarrhoea were derived, adjusting for
confounding. In the step-wise multivariate regression analysis, covariates were
included in the model in descending order of their strength of association with the
outcome variable in univariate analysis (p value ,50.1). If inclusion of a
covariate into the model produced a.10% difference in the prevalence ratios, it
was considered a confounder and left in the model. In the final models, the
Increased Access and Appropriateness of Care at Drug Shops with iCCM
PLOS ONE | DOI:10.1371/journal.pone.0115440 December 26, 2014 7 / 15
presence of interaction was also assessed. For the difference-in-difference analysis,
an interaction term for intervention status and time of assessment (baseline or
end-line) was included in the models and if significant, the coefficient of the
interaction was presented.
Ethical approval
Ethical approval was obtained from Uganda National Council of Science and
Technology (# HS 1184), the Uganda National Drug Authority (# 0456/ID/
NDA) and Makerere University School of Public Health (# 166). Written consent
was obtained from the child caretaker who was interviewed during the household
survey and exit interviews.
We report according to the Strengthening the Reporting of Observational
Studies in Epidemiology (STROBE) Statement. [17]
Role of the funding sources
The Einhorn Family Foundation had no role in study design, data collection, data
analysis, interpretation or writing the report. Medicines for Malaria Venture
participated in all the above stages. The corresponding author had full access to all
the data in the study and had the final responsibility for the decision to submit for
publication.
Results
We completed 3759 (1604 before/2155 after) households interviews and 943 (163
before/780 after) drug shop exit interviews with caretakers of children less than 5
years of age. From the baseline household survey, the comparison areas (districts)
were generally similar before the intervention with some differences only in terms
of the source of water used and the head of the household (Table 1).
From drug shop exit interviews, all febrile children were treated presumptively
with malaria drugs in both intervention and non-intervention areas before the
intervention and there were no diagnostic tests used prior to treatment. At follow-
up, while no child with fever received any diagnostic test in the non-intervention
district drug shops, nearly 90% in the intervention district had a parasitological
diagnosis of malaria with an RDT and over half with symptoms of cough and fast
breathing first had their respiratory rate counted. Treatment of diarrhoea with the
recommended drug ORS/zinc, in the intervention district drug shops was 77%
compared to only 5% in the non-intervention district, Table 2.
The effect of the intervention at the level of the drug shop was: almost total
replacement of the obsolete antibiotic cotrimoxazole from the intervention area,
three times better access to amoxicillin, the recommended drug for pneumonia
and a reduction in overall antibiotic use by 18% in the intervention area as
compared to the non-intervention area (Table 3). In addition, there was thirteen
times better access to ORS/zinc for diarrhoea in the intervention district compare
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to the non-intervention district. From the direct observation of drug sellers, 88%
of sick children presenting at drug shops with fever, cough or diarrhoea were
appropriately managed according to the iCCM guidelines (Fig. 2; Table 4).
Table 1. Characteristics of participating children and caretakers from household survey.
BEFORE AFTER
Non-Intervention Intervention p-value Non-Intervention Intervention
N5811 N5794 N51076 N51079
n (%) n (%) n (%) n (%)
Child’s gender – male 371 (48.2) 392 (49.9) 0.5 516 (48.9) 548 (51)
Caretaker’s highest level of education - primary school 451 (55.7) 457 (57.6) 0.4 637 (59.2) 668 (61.9)
Marital status – married 744 (91.7) 725 (91.3) 0.8 952 (88.5) 992 (91.9)
Caretaker’s employment – subsistence farmer/housewife 726 (89.5) 727 (91.6) 0.2 993 (92.3) 1029 (95.4)
Floor type – hard earth/mud 625 (77.1) 623 (79.6) 0.2 828 (77.1) 904 (83.8)
Main type of fuel for cooking – firewood 745 (91.9) 745 (93.8) 0.1 985 (91.5) 1,015 (94.1)
Main source of water – bore hole 691 (85.2) 737 (92.8) ,0.01 953 (88.6) 1,022 (94.7)
Head of household – partner/husband* 716 (88.4) 607 (76.5) ,0.01 927 (86.2) 869 (80.5)
Continuous variables Mean (SD) Mean (SD) Mean (SD) Mean (SD)
Child’s age (months) 18.1 (13.6) 17.6 (13.1) 0.5 20.3 (14.2) 17.5 (12.2)
Caretaker’s age (years) 29.5 (8.6) 30.1 (9.7) 0.2 28.5 (7.9) 27.9 (8.1)
*This reflects that the caregiver is often not the head of the household.
doi:10.1371/journal.pone.0115440.t001
Table 2. Symptoms and management of fever, cough with fast breathing and diarrhoea in children below 5 years of age at drug shop exit interviews (survey
adjusted).
Non-intervention Intervention Difference
Before After Before After % (95% CI)
N583 N5283 N580 N5497
Management n (%) n (%) n (%) n (%)
p-
value
Children who had fever 71/83 (85.5) 275/283 (97.2) 74/80 (92.5) 487/497 (98.0)
- Malaria RDT used to make diagnosis 0/71 (0) 0/275 (0) 0/74 (0) 427/487 (87.7) 87.7 (79.0–96.4) ,0.000-
1
– Malaria RDT used and ACT dispensed 0/71 (0) 0/275 (0) 0/74 (0) 343/487 (70.4) 70.4 (60.4–80.4) ,0.000-
1
Children with cough & fast breathing (pneumonia) 8/83 (9.6) 45/283 (15.9) 24/80 (30) 73/497 (14.7)
- Amoxicillin (5–7 days) dispensed 0/8 (0) 12/45 (26.7) 0/24 (0) 55/73 (75.3) 48.6 (44.3–53.1) ,0.000-
1
- Respiratory timer used 0/8 (0) 0/45 (0) 0/24 (0) 40/73 (54.8) 54.8 (33.8–75.8) ,0.000-
1
- Respiratory timer used and amoxicillin dispensed 0/8 (0) 0/45 (0) 0/24 (0) 36/73 (49.3) 49.3 (27.4–71.2) ,0.000-
1
Children with diarrhoea 25/83 (30.1) 111/283 (39.2) 31/80 (38.8) 176/497 (35.4)
- ORS and zinc dispensed 0/25 (0) 6/111 (5.4) 0/31 (0) 136/176 (77.3) 71.9 (67.7–74.1) ,0.000-
1
doi:10.1371/journal.pone.0115440.t002
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Results similar to those obtained from the direct observation exercise were
obtained during repeated routine support supervision visits.
The effect of the intervention at household survey level was: three times better
access to malaria rapid diagnostic tests for children reported to have fever in the
Table 3. The effect of the intervention on treatment using antibiotics, ACTs and ORS/zinc, by survey-adjusted prevalence ratios using difference in difference
analysis and generalized linear models.
Non-intervention Intervention
Prevalence
ratios
Before After Before After PR (95% CI)
N583 N5283 N580 N5497
Management n (%) n (%) n (%) n (%)
Children with pneumonia treated with amoxicillin (5–7 days) 0/8 (0) 12/45 (26.7) 0/24 (0) 55/73 (75.3) a2.8 (2.0–3.9)
Children with pneumonia treated with cotrimoxazole 3/8 (37.5) 11/45 (24.4) 19/24 (79.2) 2/73 (2.7) 0.07 (0.01–0.39)
Overall antibiotic use 54/80 (65.1) 208/283 (73.5) 36/86 (45.0) 298/497 (60.0) 0.82(0.69–0.97)
Children with fever treated with ACT 27/71 (38.0) d113/275 (41.1) 12/74 (16.2) 393/487 (80.7) c,4.2 (1.9–9.4)
Children with diarrhoea treated with ORS/zinc 0/25 (0) 6/111 (5.4) 0/35 (0) 136/176 (77.3) a,b12.8 (4.2–
38.6)
Note: Adjustment for various possible confounders including age, caretaker’s gender, caretaker’s highest education, employment etc did not change most
results. Adjusted results are reported below only where changes were statistically significant.
aComputed between intervention and control, at end-line only because of presence of zero cells at baseline.
bAdjusted for child-age (un-adjusted 514.3, 95% CI 4.8–42.4).
cAdjusted for employment status (unadjusted 54.1, 95%CI 1.8–9.2).
dAdditional febrile children were treated with quinine (23%), chloroquine (5%) and sulfadoxine/pyrimethamine (4%).
doi:10.1371/journal.pone.0115440.t003
Fig. 2. Quality of assessment of children at drug shops, from direct observations in the intervention
area.
doi:10.1371/journal.pone.0115440.g002
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intervention district compared to the non-intervention district (Prevalence ratio
3.2, 95% CI 1.9–5.4) and about 30% less use of artemisinin combination therapy
in the intervention district for fever in children as compared to the non-
intervention district (Prevalence ratio 0.74, 95% CI 0.65–0.84), Table 5. There was
also decreased use of the obsolete antibiotic cotrimoxazole for reported
pneumonia symptoms in the intervention area compared to the non-intervention
district (Prevalence ratio 0.45, 95% CI 0.27–0.47) while treatment of diarrhoea
with ORS/zinc was two times better in the intervention district as compared to the
non-intervention district (Table 5).
Treatment seeking at a government health facility for children with an illness
less than 2 weeks prior to the interview remained the same between baseline and
follow-up in the intervention and non-intervention districts (Table 6). In the
intervention district, utilization of registered drug shops increased from 29.4% at
baseline to 55.1% at follow-up and this increase came mainly from unregistered
drug shops and other informal private sector.
Discussion
We demonstrate that it is possible to adopt and utilize iCCM for management of
fever in children in private-sector registered drug shops to improve access and
appropriateness of treatment.
Table 4. Appropriateness of management of children at drug shops, from direct observation in the intervention area (N549).
Management n (%)
Fever management
Complained of fever 47/49 (96)
Number who received malaria RDT test 44/47 (94)
Positive malaria RDT 33/44 (75)
Received recommended treatment with ACTs 33/33 (100)
Number with negative RDT who received anti-malaria drug 1/11 (9)
Pneumonia management
Complained of cough 30/49 (61)
Respiratory rate counted 30/30 (100)
High respiratory rate (diagnosis pneumonia) 25/30 (83)
High respiratory rate and received amoxicillin 24/25 (96)
High respiratory rate and no amoxicillin 1/25 (4)
Low respiratory rate and no amoxicillin given 5/5 (100)
Challenge with counting respiratory rate 2/30 (7)
Respiratory rate counted when no cough 4/49 (8)
Diarrhoea Management
Children with diarrhoea 14/49 (29)
Children with diarrhoea who received ORS/Zinc 13/14 (93)
doi:10.1371/journal.pone.0115440.t004
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At follow up, nearly 90% of febrile children who sought care at registered drug
shops in the intervention district received a malaria rapid diagnostic test and more
than half of children with cough and fast breathing first had their respiratory rate
counted prior to receiving treatment. About three quarters of children with
diarrhoea received the recommended treatment with ORS/zinc.
Furthermore, from both household surveys and exit interviews, overall
antibiotic use reduced in the intervention area and the use of the obsolete
antibiotic, cotrimoxazole, for treatment of pneumonia was greatly reduced (97%
at the level of drug shops and 55% at population level). Also, from the household
survey, parasitological diagnosis of malaria was higher in the intervention area
contributing partly to the lower use of ACTs there.
While we found increased utilization of drug shops in the intervention district,
this increase came from people already utilizing the private sector with a shift
Table 5. Survey adjusted appropriateness of management of illness within the last 2 weeks, from household survey.
Management Non-intervention Intervention
Before After Before After
Prevalence Ratio
(CI)
N5457 N5711 N5483 N5748
n (%) n (%) n (%) n (%)
Children who had fever 426/457 (93.2) 695/711 (97.7) 452/483 (93.4) 718/748 (96)
- Malaria RDT used to make diagnosis - 30/695 (4.3) - 99/718 (13.8) 3.2 (1.9–5.4)
- Parasitological test for malaria performed (RDT or micro-
scopy)
- 133/695 (19.1) - 170/718 (23.7) 1.2 (1.01–1.5)
- Received Artemisinin combination therapy 203/426(47.7) 468/695 (67.3) 152/452 (33.6) 362/718 (50.4) 0.74 (0.65–0.84)
Children with cough + fast breathing (pneumonia) 130/457 (28.4) 216/711 (30.4) 143/483 (29.6) 219/748 (29.3)
- Respiratory rate timer used 0 0 0 9/219 (4.1)
- Cotrimoxazole treatment 120/184 (65.2) 155/278 (55.8) 84/193 (43.5) 46/219 (21.0) 0.45 (0.27–0.74)
- Amoxicillin treatment 40/130(30.8) 62/216 (28.7) 45/143 (31.5) 56/219 (25.6) 0.82 (0.58–1.2)
Children with diarrhoea 246/457 (53.8) 387/711 (54.4) 270/483 (55.9) 432/748 (55.1)
- ORS and Zinc treatment 0 10/387 (2.6) 0 26/432 (6) 2.3 (1.2–4.7)
doi:10.1371/journal.pone.0115440.t005
Table 6. First source of care for children with an illness less than 2 weeks prior to interview, in the household interviews.
Non-intervention Intervention
Before After p-value Before After P value
N5457 N5711 N5483 N5748
n (%) n (%) n (%) n (%)
Government health facility 84 (18.3) 127 (17.9) 0.8 101 (20.9) 154 (20.6) 0.9
Managed at home 149 (32.6) 305 (42.9) ,0.001 79 (16.4) 130 (17.4) 0.7
Drug shop 137 (30) 246 (34.6) 0.1 142 (29.4) 412 (55.1) ,0.001
Other private sector* 72 (15.8) 31(4.4) ,0.001 145 (30.0) 41 (5.5) ,0.001
Others 15 (3.3) 2 (0.3) ,0.001 16 (3.3) 11 (1.5) 0.04
*his was mainly the informal/unregistered private sector.
doi:10.1371/journal.pone.0115440.t006
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mainly from unregistered drugs shops and vendors to the participating, registered
drug shops. The overall utilization of government health facilities (rural health
centre and hospital) as the first source of care remained the same in the
intervention district both at baseline (20.9%) and at follow up (20.6%). We could
therefore allay fears in this context that interventions at drug shops will distort the
health system at the expense of the public sector. [18, 19] Similar results have been
shown from Kenya after intervention with subsidized ACTs in retail shops. [20]
The proportion of children managed at home in the intervention district
remained the same both at baseline (16.4%) and at follow up (17.4%) and
increased in the non-intervention district. This indicates continued need for
interventions targeting caretakers for better home care, e.g. by means of
Community Health Workers and iCCM.
Recently, there has been considerable debate about the role of the AMFm in
improving access to quality malaria treatment in low income countries through
drug shops. [10, 15, 18, 21, 22, 23] The Global Fund board decided in November
2012 to integrate the AMFm into core grant management and financial processes.
[22] From 2014, countries will now apply for funding to subsidize ACTs through
their usual Global Fund applications. In many cases these efforts will be combined
with malaria RDT introduction in private sector. As countries enter this next
phase of private sector intervention, it will be imperative to ensure correct
management of febrile children with appropriate differential diagnosis and
treatment also of non-malaria fevers.
The iCCM strategy is effective in reducing both morbidity and mortality in
febrile children. [24, 25, 26] However, there are numerous challenges with scaling-
up iCCM, especially around the sustainability of the intervention in terms of
salaries and motivation of community health workers and national ownership of
the intervention [27]. In some countries like Uganda, only 30% of the districts
have trained and active CHWs. Private sector drug shops will therefore remain an
important source of care for the foreseeable future. Involving them in the
campaign for better care for children is a potential game changer that could
contribute to lowering child mortality. Private and public sector care must both
be embraced and enhanced to ensure well-functioning pluralistic health systems.
[28, 29, 30]
Care should be taken when interpreting and generalizing these results. First, we
used one intervention and one non-intervention district in a high malaria
transmission area in Uganda and collected data at two time points, at baseline and
at follow up. However, the use of multiple methods of data collection - exit
interviews, direct observation and household surveys - which produced similar
results improves the strength of the results. Secondly, the malaria rapid diagnostic
tests used in this study were provided free of charge so different subsidy levels for
RDTs need to be explored for iCCM at drug shops. Finally, we did not cross check
the diagnostic test results real time during the exit interviews in order not to
interfere with drug seller practice. However, we conducted the quality of
assessment exercise where a nurse trained in iCCM observed the drug sellers
diagnosing and treating children and then re-assessed the children, for
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comparison. This quality of assessment exercise showed about 90% correct
management of children by drug sellers.
This study shows that in high malaria prevalence areas in rural Uganda, the
iCCM strategy may be adapted for utilization at registered drug shops to diminish
the presumptive treatment of malaria and to increase the integrated assessment
and care of children with fever. AMFm and other private sector initiatives should
follow the path of the public sector from presumptive, vertical management of
malaria only to integrated management of the sick child. Further research is
necessary in low malaria prevalence areas and on methods for cost recovery of
RDTs.
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